COVID-19 vaccination in India
India began administration of COVID-19 vaccines on 16 January 2021. As of 23 September 2021, India has administered over 840 million doses overall, including first and second doses of the currently-approved vaccines. India initially approved the Oxford–AstraZeneca vaccine (manufactured under license by Serum Institute of India under the trade name Covishield) and Covaxin (a vaccine developed ...
Mehr Details